Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Tuberculosis

  Free Subscription


Articles published in Am J Respir Crit Care Med

Retrieve available abstracts of 62 articles:
HTML format
Text format



Single Articles


    June 2017
  1. METCALFE JZ, Streicher E, Theron G, Colman RE, et al
    Cryptic Micro-heteroresistance Explains M. tuberculosis Phenotypic Resistance.
    Am J Respir Crit Care Med. 2017 Jun 14. doi: 10.1164/rccm.201703-0556.
    PubMed     Text format     Abstract available


  2. BURZYNSKI J
    The Use of Modeling to Compare Tuberculosis Dynamics in Four US States.
    Am J Respir Crit Care Med. 2017 Jun 13. doi: 10.1164/rccm.201705-0963.
    PubMed     Text format    


  3. GRANDJEAN L
    Investigating the Pathogen Genomic Determinants of Tuberculosis Transmission.
    Am J Respir Crit Care Med. 2017;195:1418-1420.
    PubMed     Text format    



  4. Erratum: New Guidelines for the Treatment of Drug-Susceptible Tuberculosis from the American Thoracic Society, Centers for Disease Control and Prevention, and the Infectious Diseases Society of America: Now Comes the Hard Part.
    Am J Respir Crit Care Med. 2017;195:1540.
    PubMed     Text format    


    May 2017
  5. SHRESTHA S, Hill AN, Marks SM, Dowdy DW, et al
    Comparing Drivers and Dynamics of Tuberculosis (TB) in California, Florida, New York and Texas.
    Am J Respir Crit Care Med. 2017 May 5. doi: 10.1164/rccm.201702-0377.
    PubMed     Text format     Abstract available


  6. SHAH JA, Musvosvi M, Shey M, Horne DJ, et al
    A Functional TOLLIP Variant is Associated with BCG-Specific Immune Responses and Tuberculosis.
    Am J Respir Crit Care Med. 2017 May 2. doi: 10.1164/rccm.201611-2346.
    PubMed     Text format     Abstract available


  7. SCHLUGER NW
    AJRCCM: 100-Year Anniversary. Focus on Tuberculosis.
    Am J Respir Crit Care Med. 2017;195:1112-1114.
    PubMed     Text format    


  8. ALLINSON JP, Mackay AJ, Shah PL
    AJRCCM: 100-Year Anniversary. Special Historical Image Section: Tuberculosis Then and Now.
    Am J Respir Crit Care Med. 2017;195:1118-1123.
    PubMed     Text format    


    April 2017
  9. DIACON AH, van Brakel E, Lounis N, Meyvisch P, et al
    Triplicate Sputum Cultures for Efficacy Evaluation of Novel Anti-tuberculosis Regimens.
    Am J Respir Crit Care Med. 2017 Apr 27. doi: 10.1164/rccm.201704-0796.
    PubMed     Text format    


    March 2017
  10. DEDICOAT MJ, Gunther G, Crudu V, Duarte R, et al
    Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure.
    Am J Respir Crit Care Med. 2017 Mar 21. doi: 10.1164/rccm.201612-2585.
    PubMed     Text format    


    February 2017

  11. What is Tuberculosis (TB)?
    Am J Respir Crit Care Med. 2017;195:P7-P8.
    PubMed     Text format    


    December 2016
  12. NEBENZAHL-GUIMARAES H, van Laarhoven A, Farhat MR, Koeken VA, et al
    Transmissible Mycobacterium tuberculosis Strains Share Genetic Markers and Immune Phenotypes.
    Am J Respir Crit Care Med. 2016 Dec 20. doi: 10.1164/rccm.201605-1042.
    PubMed     Text format     Abstract available


  13. DARTOIS V, Saito K, Warrier T, Nathan C, et al
    New Evidence for the Complexity of the Population Structure of Mycobacterium tuberculosis Increases the Diagnostic and Biologic Challenges.
    Am J Respir Crit Care Med. 2016;194:1448-1451.
    PubMed     Text format    


    November 2016
  14. LEU JS, Chen ML, Chang SY, Yu SL, et al
    SP110b Controls Host Immunity and Susceptibility to Tuberculosis.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


  15. HARAUSZ EP, Garcia-Prats AJ, Seddon JA, Schaaf HS, et al
    New/Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis: Practice-Based Recommendations.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


  16. GUGLIELMETTI L, Le Du D, Frechet-Jachym M, Mitnick C, et al
    Preventing Acquired Resistance to Bedaquiline and Delamanid in Multidrug-Resistant Tuberculosis Treatment Requires Optimal Management.
    Am J Respir Crit Care Med. 2016;194:1170-1171.
    PubMed     Text format    


  17. SAUNDERS MJ, Datta S
    Contact Investigation: A Priority for Tuberculosis Control Programs.
    Am J Respir Crit Care Med. 2016;194:1049-1051.
    PubMed     Text format    


    October 2016
  18. VARAINE F, Guglielmetti L, Huerga H, Bonnet M, et al
    Eligibility for the Shorter Multidrug-Resistant Tuberculosis Regimen: Ambiguities in the World Health Organization Recommendations.
    Am J Respir Crit Care Med. 2016;194:1028-1029.
    PubMed     Text format    


    September 2016
  19. SMALL PM
    Making Tuberculosis Care and Control Easy Again.
    Am J Respir Crit Care Med. 2016;194:537-538.
    PubMed     Text format    


    August 2016
  20. METERSKY ML, Schluger NW
    New Guidelines for the Treatment of Drug-susceptible Tuberculosis from the American Thoracic Society, Centers for Disease Control and the Infectious Disease Society of America: Now Comes the Hard Part.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format    


  21. WHALEN CC
    The Replacement Principle of Tuberculosis. Why Prevention Matters.
    Am J Respir Crit Care Med. 2016;194:400-1.
    PubMed     Text format    


  22. FOIS A, Trisolini R, Canu S, Pirina P, et al
    Tuberculosis-induced Fish-scale Degeneration of the Central Airways.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format    


    July 2016
  23. KOENIG SP, Furin J
    Update in Tuberculosis/Pulmonary Infections 2015.
    Am J Respir Crit Care Med. 2016;194:142-6.
    PubMed     Text format    


  24. CHENGALROYEN MD, Beukes GM, Gordhan BG, Streicher EM, et al
    Detection and Quantification of Differentially Culturable Tubercle Bacteria in Sputum from Tuberculosis Patients.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


    June 2016
  25. ZENNER D, Ashkin D
    Diagnosis of Latent Tuberculosis Infection in HIV-infected Pregnant Women. "Baby Steps" toward Better Tuberculosis Control in Pregnancy.
    Am J Respir Crit Care Med. 2016;193:1332-3.
    PubMed     Text format    


  26. WILKINSON KA, Oni T, Gideon HP, Goliath R, et al
    Activation Profile of Mycobacterium tuberculosis-Specific CD4(+) T Cells Reflects Disease Activity Irrespective of HIV Status.
    Am J Respir Crit Care Med. 2016;193:1307-10.
    PubMed     Text format    


    May 2016
  27. MARTINEZ L, Sekandi JN, Castellanos ME, Zalwango S, et al
    Infectiousness of HIV Seropositive Tuberculosis Patients in a High-burden African Setting.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


    February 2016
  28. FARHAT MR, Sultana R, Iartchouk O, Bozeman S, et al
    Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic Value.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


  29. GHASSEMIEH BJ, Attia EF, Koelle DM, Mancuso JD, et al
    Latent Tuberculosis Infection Test Agreement in the National Health and Nutrition Examination Survey.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


  30. BUSCH M, Herzmann C, Kallert S, Zimmermann A, et al
    Lipoarabinomannan-responsive Polycytotoxic T Cells are Associated With Protection in Human Tuberculosis.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


  31. MANCUSO JD, Diffenderfer JM, Ghassemieh BJ, Horne DJ, et al
    The Prevalence of Latent Tuberculosis Infection in the United States.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


  32. HOFFMANN H, Kohl TA, Hofmann-Thiel S, Merker M, et al
    Delamanid and Bedaquiline Resistance in Mycobacterium tuberculosis Ancestral Beijing Genotype Causing Extensively Drug-Resistant Tuberculosis in a Tibetan Refugee.
    Am J Respir Crit Care Med. 2016;193:337-40.
    PubMed     Text format    


    January 2016
  33. MATHAD JS, Bhosale R, Balasubramanian U, Kanade S, et al
    Quantitative IFN-gamma,IL-2 Response and Latent Tuberculosis Test Discordance in HIV-infected Pregnant Women.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


    December 2015
  34. MATTHEWS K, Deffur A, Ntsekhe M, Syed F, et al
    A Compartmentalized Profibrotic Immune Response Characterizes Pericardial Tuberculosis, Irrespective of HIV-1 Infection.
    Am J Respir Crit Care Med. 2015;192:1518-1521.
    PubMed     Text format    


    October 2015
  35. KING TC, Upfal M, O'Dea LS
    Reply: Revisiting Healthcare Workers as a Risk Group for Progression toward Tuberculosis.
    Am J Respir Crit Care Med. 2015;192:1022-1023.
    PubMed     Text format    


  36. OLARU ID, Lange C, Sester M
    Revisiting Healthcare Workers as a Risk Group for Progression toward Tuberculosis.
    Am J Respir Crit Care Med. 2015;192:1021-1022.
    PubMed     Text format    


  37. CUSUMANO G, Bellofiore S, Montineri A, Emanuele R, et al
    Pott's Disease of the Thoracic Spine and Abscess of the Chest Wall.
    Am J Respir Crit Care Med. 2015;192:e51-2.
    PubMed     Text format    


  38. ELKINGTON P, Zumla A
    Update in Mycobacterium tuberculosis Lung Disease 2014.
    Am J Respir Crit Care Med. 2015;192:793-798.
    PubMed     Text format    


    September 2015
  39. GLEESON LE, Keane J
    First Steps in Biomarker Assessment for Reactivation Risk in Latent Tuberculosis Infection.
    Am J Respir Crit Care Med. 2015;192:534-5.
    PubMed     Text format    


  40. GRIFFITH DE
    Nontuberculous Mycobacterial Disease Research. An End to the Beginning.
    Am J Respir Crit Care Med. 2015;192:535-7.
    PubMed     Text format    


  41. SZYMANSKI EP, Leung JM, Fowler CJ, Haney C, et al
    Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease.
    Am J Respir Crit Care Med. 2015;192:618-28.
    PubMed     Text format     Abstract available


    August 2015
  42. MURRAY JF
    Tuberculosis and World War I.
    Am J Respir Crit Care Med. 2015;192:411-4.
    PubMed     Text format    


  43. GOMEZ-PASTRANA D, Dominguez J
    Diagnosis of Tuberculosis in Children Using Mycobacteria-Specific Cytokine Responses. Are There Reasons for Hope?
    Am J Respir Crit Care Med. 2015;192:409-10.
    PubMed     Text format    


  44. BOEREE MJ, Diacon AH, Dawson R, Narunsky K, et al
    A Step toward an Optimized Rifampin Dose Completed.
    Am J Respir Crit Care Med. 2015;192:525-6.
    PubMed     Text format    


  45. MILLER SL
    Upper Room Germicidal Ultraviolet Systems for Air Disinfection Are Ready for Wide Implementation.
    Am J Respir Crit Care Med. 2015;192:407-9.
    PubMed     Text format    


  46. TEBRUEGGE M, Dutta B, Donath S, Ritz N, et al
    Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
    Am J Respir Crit Care Med. 2015;192:485-99.
    PubMed     Text format     Abstract available


  47. GARCIA-BASTEIRO AL, Ismail MR, Carrilho C, Ussene E, et al
    "Pomegranate" Spleen in Disseminated Tuberculosis.
    Am J Respir Crit Care Med. 2015;192:387-388.
    PubMed     Text format    


  48. KING TC, Upfal M, Gottlieb A, Adamo P, et al
    T-SPOT.TB Interferon-gamma Release Assay Performance in Healthcare Worker Screening at Nineteen U.S. Hospitals.
    Am J Respir Crit Care Med. 2015;192:367-73.
    PubMed     Text format     Abstract available


    July 2015
  49. BOTHAMLEY GH
    Fluoroquinolone Preventive Therapy after Exposure to Multidrug-Resistant Tuberculosis? Hopes and Fears.
    Am J Respir Crit Care Med. 2015;192:131-2.
    PubMed     Text format    


  50. GEBHARD A, van den Hof S, Cobelens F
    How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?
    Am J Respir Crit Care Med. 2015;192:117.
    PubMed     Text format    


  51. BASTARD M, Bonnet M, du Cros P, Khamraev AK, et al
    Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?
    Am J Respir Crit Care Med. 2015;192:117-118.
    PubMed     Text format    


  52. MUKHERJEE V, Bender WS, Egan JP 3rd
    Inhaled Antibiotics for Refractory Nontuberculous Mycobacteria and Non-Cystic Fibrosis Bronchiectasis and the Significance of Mycobacterium abscessus subsp. abscessus Isolation during M. avium Complex Lung Disease Therapy.
    Am J Respir Crit Care Med. 2015;192:106-108.
    PubMed     Text format    


  53. BISCHOF JE, Chingsanoon A, Nanthavong P, Vidhamaly S, et al
    Contained Rupture of a Tuberculous Mycotic Aortic Aneurysm Detected by Bedside Ultrasound.
    Am J Respir Crit Care Med. 2015;192:e1-e2.
    PubMed     Text format    


    June 2015
  54. CAMINERO JA, Migliori GB
    Automated Digital Microscopy in New Tuberculosis Diagnostic Algorithms. Can It Boost Case Finding?
    Am J Respir Crit Care Med. 2015;191:1352-3.
    PubMed     Text format    


  55. ESCALANTE P, Peikert T, Van Keulen VP, Erskine CL, et al
    Combinatorial Immunoprofiling in Latent Tuberculosis Infection: Toward Better Risk Stratification.
    Am J Respir Crit Care Med. 2015.
    PubMed     Text format     Abstract available


    May 2015

  56. Erratum: daily rifapentine for treatment of pulmonary tuberculosis: a randomized, dose-ranging trial.
    Am J Respir Crit Care Med. 2015;191:1210.
    PubMed     Text format    


  57. ACCINELLI RA, Romero LR, Garcia RF, Sanchez R, et al
    Sustained Benefit of Community-based Tuberculosis Interventions after 30 Years.
    Am J Respir Crit Care Med. 2015;191:1202-3.
    PubMed     Text format    


  58. VOSKUIL MI, Schlesinger LS
    Toward Resolving the Paradox of the Critical Role of the DosR Regulon in Mycobacterium tuberculosis Persistence and Active Disease.
    Am J Respir Crit Care Med. 2015;191:1103-5.
    PubMed     Text format    


  59. ZUMLA A, Maeurer M
    IFN-gamma Release Assays for Risk Assessment in Contacts of Patients with Tuberculosis in Low-Burden European Countries.
    Am J Respir Crit Care Med. 2015;191:1101-3.
    PubMed     Text format    


  60. MENZIES D
    Finishing what they started: when do researchers' responsibilities end?
    Am J Respir Crit Care Med. 2015;191:977-8.
    PubMed     Text format    


    April 2015
  61. DIACON AH, Dawson R, von Groote-Bidlingmaier F, Symons G, et al
    Bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquiline.
    Am J Respir Crit Care Med. 2015;191:943-53.
    PubMed     Text format     Abstract available


  62. GROSSET J, Vernon A
    A reader's guide to the bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquiline.
    Am J Respir Crit Care Med. 2015;191:871-3.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: